NEW
Lorviqua

Lorviqua Contraindications

lorlatinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Full Prescribing Info
Contraindications
Hypersensitivity to lorlatinib or to any of the excipients listed in Description.
Concomitant use of strong CYP3A inducers with lorlatinib is contraindicated due to the potential for serious hepatotoxicity (aspartate aminotransferase [AST] and alanine aminotransferase [ALT] elevations) (see Precautions and Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in